The Frontline EEG Solution for Continuous Monitoring and Improved Patient Outcomes

Ceribell empowers clinicians to make timely, informed treatment decisions, reducing hospital length of stay and unnecessary interventions while promoting hospital-wide efficiencies

The Ceribell Solution

The Ceribell EEG System is designed to provide:

  • Rapid EEG set up within minutes with minimal training1
  • Continuous monitoring and alerts at the bedside for status epilepticus
  • Remote access to real-time EEG information for neurology
electrographic status epilepticus

Clarity AI helps individuals with no background in EEG detect and rule out NCSE with remarkable accuracy2,3

Ceribell with Clarity offers 24/7 EEG monitoring and alerts for electrographic status epilepticus, also known as non-convulsive status epilepticus (NCSE).
  • First FDA-cleared instantaneous bedside alert indicating suspected status epilepticus4
  • Continuous EEG monitoring and seizure burden display
Learn More

Real-time streaming of EEG data to a cloud-based portal enables physicians to review EEG data from anywhere

Ceribell EEG Portal
  • Signal quality equivalent to conventional EEG5
  • EEG labeling throughout the recording to improve EEG reading efficiency
  • Seizure burden trend for effective seizure management and real-time feedback on medication effectiveness
Learn about the EEG Portal

Ceribell Helps

Improve confidence in clinical decisions

Guide treatment decisions

Patients avoid potentially unnecessary medication and intubation
decorative

Resources

featured resources orange dot

Webinar: Evidence-based Insights for Non-convulsive Seizure Triage & Management in Critical and Emergency Care

Watch Our Webinar

Webinar

featured resources orange dot

Health Economics and Staffing Webinar: Expanding Care with Ceribell Rapid EEG Improves Staff Satisfaction and Finances

Watch Our Webinar

Webinar

featured resources orange dot

Health Economics and Staffing Webinar: Stopping unnecessary patient transfers: How a Point-of-Care EEG impacted our transfers and bottom line

Watch Our Webinar

Webinar

References and Citations

1. Vespa, P.M., et al. (2020) Crit Care Med. 48(9):1249-1257
2. Kamousi, B., et al. (2021) Neurocrit Care. 34(3):908-917
3. Kamousi, B., et al. (2023) NCS Annual Meeting. 39:s1-s268
4. FDA 510k Clearance Letter K223504
5. Kamousi, B., et al. (2019) Clin Neurophysiol Practice. 4:69-75